Accurate Clinical Research

Accurate Clinical Research is a service provider in the clinical research organization (CRO) and site management sector. Founded by Dr. Philip Waller and Karen Obmaces, the company leverages over 30 years of collective management experience to conduct Phase Ib through Phase III and post-approval trials across multiple therapeutic areas. Its business model is based on contracting with sponsors to recruit patients, manage trial protocols, and collect data, with a reported track record of exceeding patient enrollment targets. The company appears to be a revenue-generating, private entity focused on operational execution rather than developing its own therapeutic assets.

Operational platform for clinical trial execution, featuring an integrated in-house team (coordinators, regulatory, recruitment, nurses), use of central IRBs, and a focus on high-performance patient enrollment metrics.

ACR competes in the fragmented clinical research site sector, facing competition from large Site Management Organizations (SMOs), hospital-based academic research centers, and other independent investigative sites. Its differentiation is based on claimed enrollment speed, operational integration, and therapeutic breadth.